Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C26H26N2O3 |
| Molecular Weight | 414.4962 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C(=O)C2=CN(CCN3CCOCC3)C4=C2C=CC=C4)C5=C1C=CC=C5
InChI
InChIKey=QWHSUXWDDKWTOG-UHFFFAOYSA-N
InChI=1S/C26H26N2O3/c1-30-25-11-10-22(19-6-2-3-8-21(19)25)26(29)23-18-28(24-9-5-4-7-20(23)24)13-12-27-14-16-31-17-15-27/h2-11,18H,12-17H2,1H3
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-JWH-198
Created by
admin on Sat Dec 16 11:17:34 GMT 2023 , Edited by admin on Sat Dec 16 11:17:34 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
J53IGM38PB
Created by
admin on Sat Dec 16 11:17:34 GMT 2023 , Edited by admin on Sat Dec 16 11:17:34 GMT 2023
|
PRIMARY | |||
|
DTXSID40168133
Created by
admin on Sat Dec 16 11:17:34 GMT 2023 , Edited by admin on Sat Dec 16 11:17:34 GMT 2023
|
PRIMARY | |||
|
JWH-198
Created by
admin on Sat Dec 16 11:17:34 GMT 2023 , Edited by admin on Sat Dec 16 11:17:34 GMT 2023
|
PRIMARY | JWH 198 is a synthetic cannabinoid (CB) which binds the central CB1 receptor with high affinity (Ki = 10 nM).1 This aminoalkylindole shares structural features with the antinociceptive CB1 agonists pravadoline (Item No. 10006973) and WIN 55,212-2.1 The physiological and toxicological properties of this compound have not been investigated. | ||
|
166599-76-4
Created by
admin on Sat Dec 16 11:17:34 GMT 2023 , Edited by admin on Sat Dec 16 11:17:34 GMT 2023
|
PRIMARY | |||
|
10319620
Created by
admin on Sat Dec 16 11:17:34 GMT 2023 , Edited by admin on Sat Dec 16 11:17:34 GMT 2023
|
PRIMARY | |||
|
JWH-198
Created by
admin on Sat Dec 16 11:17:34 GMT 2023 , Edited by admin on Sat Dec 16 11:17:34 GMT 2023
|
PRIMARY | JWH-198 is a drug from the aminoalkylindole family which acts as a cannabinoid receptor agonist. It was invented by the pharmaceutical company Sanofi-Winthrop in the early 1990s. JWH-198 has a binding affinity at the CB1 receptor of 10nM, binding around four times more tightly than the parent compound JWH-200, which has no substitution on the naphthoyl ring.(1) It has been used mainly in molecular modelling of the cannabinoid receptors. |
ACTIVE MOIETY
